Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002353 · ClinicalTrials.gov registry record · Phase 1
A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects
A Phase 1 study, sponsored by United Biomedical.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002353: Completed Phase 1 study, sponsored by United Biomedical.
NCT00002353 is a Phase 1 study that has completed, run by United Biomedical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002353, a Phase 1 study, has completed, sponsored by United Biomedical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
To evaluate an HIV lipopeptide immunotherapeutic, P3C541b, at two dose levels administered subcutaneously in HIV-seropositive patients.
Interventions
- BIOLOGICAL P3C541b Lipopeptide
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00002353 record still lists
NCT00002353 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which P3C541b Lipopeptide is the first listed.
NCT00002353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002353 about?
NCT00002353 is a clinical study titled "A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects". To evaluate an HIV lipopeptide immunotherapeutic, P3C541b, at two dose levels administered subcutaneously in HIV-seropositive patients.
What is the current status of trial NCT00002353?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00002353?
The interventions under investigation include: P3C541b Lipopeptide (BIOLOGICAL).
Who is sponsoring clinical trial NCT00002353?
This trial is sponsored by United Biomedical, which has 2 total clinical trials registered on ClinicalTrials.gov.